Company Information

  

Address: 7801 N CAPITAL OF TEXAS HIGHWAY
SUITE 260 
City: AUSTIN 
State: TX 
Zip Code: 78731 
Telephone: 512-501-2444 

Description of Business

Primary SIC Code: 2834
(As filed with the SEC)  

Pain Therapeutics, Inc. develops proprietary drugs that offer significant improvements to patients and healthcare professionals. We generally focus our drug development efforts on disorders of the nervous system. Our expertise consists of developing new drug candidates and guiding these through various regulatory and development pathways in preparation for their eventual commercialization. By necessity, the conduct of drug development is complex, lengthy, expensive and risky. The FDA has not yet established the safety or efficacy of our drug candidates. 4 -------------------------------------------------------------------------------- Reverse Stock Split On May 4, 2017, following stockholder approval, our board of directors approved a reverse stock split at a ratio of 7-for-1.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
03/2018-1.73NAN/E
12/2017-1.82NAN/E
09/2017-1.87NAN/E
06/2017-2.02NAN/E
03/2017-12.74NAN/E

Key Financial Ratios and Statistics

FYE: 12/31

Profitability 2017 Leverage 2017
Net Inc/Comm Equity-0.07Total Liab/Total Assets0.10
Net Inc/Total Assets-1.10Total Liab/Inv Cap0.12
Net Inc/Inv Cap-1.23Total Liab/Comm Equity0.01
Pretax Inc/Net SalesNAInterest Coverage RatioNA
Net Inc/Net SalesNACurr Debt/EquityNA
Cash Flow/Net SalesNALTD/EquityNA
SG&A/NetSalesNATotal Debt/EquityNA
Asset Utilization   Liquidity  
Net Receivables TurnoverNAQuick Ratio9.42
Inventory TurnoverNACurrent Ratio9.42
Inventory Day SalesNANet Rec/Curr AssetsNA
Net Sales/Work CapNAInv/Curr AssetsNA
Net Sales/PP&ENA  

Income Statement (Millions)

  3/31/2018 12/31/2017 9/30/2017 6/30/2017
Total Revenues(Net Sales) NA NA NA NA
Cost of Goods Sold NA NA NA NA
Selling & Admin Exps 1.10 0.88 0.98 1.10
Operating Income -2.17 -2.42 -2.60 -4.17
Interest Exp NA NA NA NA
Pretax Income -2.16 -2.42 -2.59 -4.16
Other Income 0.01 0.01 0.01 0.01
Net Income Bef Extraordinary ... NA NA NA NA
Net Income -2.16 -2.42 -2.59 -4.16

Balance Sheet (Millions)

Assets 3/31/2018 12/31/2017 9/30/2017 6/30/2017
Cash & Short Term Investments 10.73 10.48 11.92 14.07
Receivables - Total NA NA NA NA
Inventories - Total NA NA NA NA
Total Current Assets 10.89 10.66 12.20 14.08
Net Property, Plant & Equipment 0.14 0.16 0.17 0.19
Total Assets 11.06 10.83 12.38 14.27
Liabilities        
Accounts Payable 0.75 1.13 1.01 1.00
Debt in Current Liabilities NA NA NA NA
Total Current Liabilities 0.76 1.13 1.01 1.00
Long-Term Debt NA NA NA NA
Total Liabilities 0.76 1.13 1.01 1.00
Stockholder's Equity        
Minority Interest NA NA NA NA
Preferred Stock 0.00 0.00 0.00 0.00
Common Stock 0.01 0.01 0.01 0.01
Retained Earnings -159.56 -157.40 -154.98 -152.39
Treasury Stock NA NA NA NA
Total Stockholders' Equity 10.30 9.70 11.37 13.27
Total Liabilities and Stockholders' Equity 11.06 10.83 12.38 14.27

Cash Flow Summary (Millions)

Categories 3/31/2018 12/31/2017 9/30/2017 6/30/2017
Net Cash Provided by Operating Activities -1.64 -1.44 -2.15 -3.20
Net Cash Provided by Investing Activities 0.00 0.00 0.00 0.00
Net Cash Provided by Financing Activities 1.90 0.00 0.00 0.00

Annual Summary Data (Millions)

Year Sales Net Income EPS
12/201341.1231.54--
12/20140.00-12.39--
12/20150.00-14.14--
12/20160.00-14.85--
12/20170.00-11.91-1.82
Growth Rates-100.00----

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional06/30/18302,27132.94




Report Date : 7/16/2018

Powered By Edgar Online © 2018EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.